Altshuler Shaham’s Sarepta Therapeutics SRPT Stock Holding History

Altshuler Shaham’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-198	Closed	-$27.3K	–	392
2023 Q1	$27.3K	Sell	198 -309	-61%	-$40.1K	﹤0.01%	296
2022 Q4	$65.7K	Sell	507 -26	-5%	-$3.01K	﹤0.01%	177
2022 Q3	$58K	Buy	+533	New	+$53.7K	﹤0.01%	198
2021 Q3	–	Sell	-17	Closed	-$1K	–	654
2021 Q2	$1K	Sell	17 -2,823	-99%	-$214K	﹤0.01%	597
2021 Q1	$212K	Sell	2,840 -2,331	-45%	-$215K	﹤0.01%	194
2020 Q4	$882K	Sell	5,171 -4,000	-44%	-$593K	0.02%	77
2020 Q3	$1.29M	Sell	9,171 -660	-7%	-$100K	0.03%	70
2020 Q2	$1.58M	Hold	9,831	–	–	0.05%	48
2020 Q1	$962K	Sell	9,831 -194	-2%	-$22.2K	0.04%	51
2019 Q4	$1.29M	Buy	10,025 +115	+1%	+$11.6K	0.04%	66
2019 Q3	$755K	Buy	9,910 +104	+1%	+$12.3K	0.03%	79
2019 Q2	$1.49M	Buy	9,806 +444	+5%	+$54K	0.06%	51
2019 Q1	$1.12M	Hold	9,362	–	–	0.05%	84
2018 Q4	$1.02M	Buy	+9,362	New	+$1.17M	0.05%	86

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Altshuler Shaham's SRPT Position: Q2 2023 in Review

Altshuler Shaham sold out of Sarepta Therapeutics (SRPT) in Q2 2023, closing a stake of 198 shares — an estimated $27.3K sold.

Altshuler Shaham first reported a position in SRPT in Q4 2018 and held it in 14 quarters. The position peaked at $1.58M in Q2 2020. 404 funds tracked by Wall St. Rank hold SRPT as of Q2 2023.

Altshuler Shaham reported no remaining Sarepta Therapeutics position as of Q2 2023 after selling out during the quarter.
Altshuler Shaham sold 198 Sarepta Therapeutics shares in Q2 2023, an estimated $27.3K.
Altshuler Shaham first reported a position in Sarepta Therapeutics in Q4 2018 and held it in 14 quarters.
Altshuler Shaham's Sarepta Therapeutics position peaked at $1.58M in Q2 2020.
404 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2023.

Based on Altshuler Shaham's 13F filing for Q2 2023, filed 24 Jul 2023.